Plan B® Prescribers: Information and Support

HTML

Support Materials

Download the materials below to help you talk to patients about Plan B^®, or order printed versions by calling the Plan B^® Information Center toll-free number, 1-800-330-1271.

Plan B^® Patient Brochure:

English
En Español

Plan B^® Counseling Checklist
Prescriber's Flash Card

You need Adobe^® Reader^® installed on your computer to view these documents. You can download a copy of Adobe^® Reader^® by clicking the icon below.

Online Resources

The websites below can provide up-to-date information on emergency contraception and other women's health issues.

The American College of Obstetricians & Gynecologists
American Medical Association
American Medical Women's Association
American Pharmacists Association
American Public Health Association
Association of Reproductive Health Professionals
Family Health International
FDA Q&A on Plan B^®
Go2ec.org
International Consortium for Emergency Contraception
Managing Contraception
National Association of Nurse Practitioners in Women's Health
National Medical Association
Not-2-late.com
Pharmacy Access Partnership
Physicians for Reproductive Choice and Health
Program for Appropriate Technology in Health
Reproductive Health Technologies Projects

References

1. Task Force on Postovulatory Methods of Fertility Regulation. Randomised controlled trial of levonorgestrel versus the Yuzpe regimen of combined oral contraceptives for emergency contraception. Lancet. 1998;352:428-433.

2. The American College of Obstetricians and Gynecologists. ACOG supports safety and availability of over-the-counter emergency contraception. Available at: http://www.acog.org/from_home/publications/press-releases/nr02-28-01-2.cfm. Accessed April 4, 2005.

3. Henshaw SK. Unintended pregnancy in the United States. Family Planning Perspectives. 1998;30:24-29, 46.

4. Jones RK, Henshaw D, Henshaw SK. Contraceptive use among U.S. women having abortions in 2000-2001. Perspect Sex Reprod Health. 2002;34:294-303.

5. Dedicated emergency contraceptive pills worldwide. Available at: http://ec.princeton.edu/questions/dedicated.html. Accessed April 7, 2005.

6. The American College of Obstetricians and Gynecologists. New ACOG leader promotes widespread advance prescriptions for emergency contraception. Available at: http://www.acog.org/from_home/publications/press-releases/nr04-30-01-1.cfm. Accessed April 4, 2005.

7. The American College of Obstetricians and Gynecologists. ACOG to testify before FDA in support of over-the-counter emergency contraception. Available at: http://www.acog.org/from_home/publications/press-releases/nr12-15-03.cfm. Accessed April 4, 2005.

8. Arowojolu AO, Okewkie IA, et al. Comparative evaluation of the effectiveness and safety of two regimens of levonorgestrel for emergency contraception in Nigerians. Contraception. 2002: 66(4);269-73.

9. von Hertzen H, Piaggio G, et al. Low dose mifepristone and two regimens of levonorgestrel for emergency contraception: a WHO multicentre randomised trial. Lancet. 2002:360(9348): 1803-10

10. Hamoda H, Ashok PW, et al. A randomized trial of mifepristone (10 mg) and levonorgestrel for emergency contraception. Obstetrics & Gynecology. 2004:104(6);1307-13.

11. Kavanaugh ML, Schwarz EB. Counseling About and Use of Emergency Contraception in the United States. Perspectives on Sexual and Reproductive Health. June 2, 2008; Vol.40, Number 2.

> Prescribing Information

> FAQs

> Information and Support

Pharmacy Request Card

Tell a Colleague About Plan B^®

Important Safety Information:

For more information about Plan B^®, call 1-800-330-1271

Important Safety Information: Plan B^® is indicated to prevent pregnancy following unprotected intercourse or contraceptive failure. Plan B^® is contraindicated in women with known or suspected pregnancy, hypersensitivity to any component of the product. Plan B^® is not recommended for routine use as a contraceptive, because it isn't as effective. Plan B^® is not effective in terminating an existing pregnancy. Plan B^® does not protect against HIV infection and other sexually transmitted infections (STIs). Menstrual bleeding may be heavier or lighter, earlier or later after taking Plan B^®. If menses is delayed beyond one week, the patient may be pregnant. Severe abdominal pain may signal a tubal (ectopic) pregnancy. Common side effects associated with the use of Plan B^® include nausea, abdominal pain, fatigue, headache, menstrual changes, dizziness, breast tenderness, vomiting, and diarrhea.

Your patients are encouraged to report any negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.